Browse > Article
http://dx.doi.org/10.4046/trd.2021.0015

Correlation between Telomere Length and Chronic Obstructive Pulmonary Disease-Related Phenotypes: Results from the Chronic Obstructive Pulmonary Disease in Dusty Areas (CODA) Cohort  

Moon, Da Hye (Department of Internal Medicine, Kangwon National University Hospital)
Kim, Jeeyoung (Department of Internal Medicine and Environmental Health Center, Kangwon National University School of Medicine)
Lim, Myoung Nam (Biomedical Research Institute, Kangwon National University)
Bak, So Hyen (Department of Radiology, Kangwon National University Hospital, Kangwon National University of School of Medicine)
Kim, Woo Jin (Department of Internal Medicine, Kangwon National University Hospital)
Publication Information
Tuberculosis and Respiratory Diseases / v.84, no.3, 2021 , pp. 188-199 More about this Journal
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a common chronic respiratory disease with increased prevalence in the elderly. Telomeres are repetitive DNA sequences found at the end of the chromosome, which progressively shorten as cells divide. Telomere length is known to be a molecular marker of aging. This study aimed to assess the relationship between telomere length and the risk of COPD, lung function, respiratory symptoms, and emphysema index in Chronic Obstructive Pulmonary Disease in Dusty Areas (CODA) cohort. Methods: We extracted DNA from the peripheral blood samples of 446 participants, including 285 COPD patients and 161 control participants. We measured absolute telomere length using quantitative real-time polymerase chain reaction. All participants underwent spirometry and quantitative computed tomography scan. Questionnaires assessing respiratory symptoms and the COPD Assessment Test was filled by all the participants. Results: The mean age of participants at the baseline visit was 72.5±7.1 years. Males accounted for 72% (321 participants) of the all participants. The mean telomere length was lower in the COPD group compared to the non-COPD group (COPD, 16.81±13.90 kb; non-COPD, 21.97±14.43 kb). In COPD patients, 112 (75.7%) were distributed as tertile 1 (shortest), 91 (61.1%) as tertile 2 and 82 (55%) as tertile 3 (longest). We did not find significant associations between telomere length and lung function, exacerbation, airway wall thickness, and emphysema index after adjusting for sex, age, and smoking status. Conclusion: In this study, the relationship between various COPD phenotypes and telomere length was analyzed, but no significant statistical associations were shown.
Keywords
Telomere Length; Chronic Obstructive Pulmonary Disease; Phenotype;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Rode L, Bojesen SE, Weischer M, Vestbo J, Nordestgaard BG. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals. Thorax 2013;68:429-35.   DOI
2 Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest 2013; 123:996-1002.   DOI
3 Serrano AL, Andres V. Telomeres and cardiovascular disease: does size matter? Circ Res 2004;94:575-84.   DOI
4 Park J, Hobbs BD, Crapo JD, Make BJ, Regan EA, Humphries S, et al. Subtyping COPD by using visual and quantitative CT imaging features. Chest 2020;157:47-60.   DOI
5 Bernadotte A, Mikhelson VM, Spivak IM. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging (Albany NY) 2016;8:3-11.   DOI
6 Clouston SA, Edelman NH, Aviv A, Stewart C, Luft BJ. Shortened leukocyte telomere length is associated with reduced pulmonary function and greater subsequent decline in function in a sample of World Trade Center responders. Sci Rep 2019;9:8148.   DOI
7 Jin M, Lee EC, Ra SW, Fishbane N, Tam S, Criner GJ, et al. Relationship of absolute telomere length with quality of lfe, exacerbations, and mortality in COPD. Chest 2018;154:266-73.   DOI
8 Smith BM, Austin JH, Newell JD Jr, D'Souza BM, Rozenshtein A, Hoffman EA, et al. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med 2014;127:94.
9 Halper-Stromberg E, Cho MH, Wilson C, Nevrekar D, Crapo JD, Washko G, et al. Visual assessment of chest computed tomographic images is independently useful for genetic association analysis in studies of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2017;14:33-40.   DOI
10 Daniali L, Benetos A, Susser E, Kark JD, Labat C, Kimura M, et al. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun 2013;4:1597.   DOI
11 Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-60.   DOI
12 Albrecht E, Sillanpaa E, Karrasch S, Alves AC, Codd V, Hovatta I, et al. Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J 2014;43:983-92.   DOI
13 Dijkstra AE, Postma DS, ten Hacken N, Vonk JM, Oudkerk M, van Ooijen PM, et al. Low-dose CT measurements of airway dimensions and emphysema associated with airflow limitation in heavy smokers: a cross sectional study. Respir Res 2013;14:11.   DOI
14 Morla M, Busquets X, Pons J, Sauleda J, MacNee W, Agusti AG. Telomere shortening in smokers with and without COPD. Eur Respir J 2006;27:525-8.   DOI
15 Benetos A, Kark JD, Susser E, Kimura M, Sinnreich R, Chen W, et al. Tracking and fixed ranking of leukocyte telomere length across the adult life course. Aging Cell 2013;12:615-21.   DOI
16 Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009;135:173-80.   DOI
17 Starkweather AR, Alhaeeri AA, Montpetit A, Brumelle J, Filler K, Montpetit M, et al. An integrative review of factors associated with telomere length and implications for biobehavioral research. Nurs Res 2014;63:36-50.   DOI
18 Karrasch S, Holz O, Jorres RA. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med 2008;102:1215-30.   DOI
19 Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008; 31:869-73.   DOI
20 Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.   DOI
21 Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ. Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med 2008;44:235-46.   DOI
22 Lee J, Sandford AJ, Connett JE, Yan J, Mui T, Li Y, et al. The relationship between telomere length and mortality in chronic obstructive pulmonary disease (COPD). PLoS One 2012;7: e35567.   DOI
23 Mather KA, Jorm AF, Parslow RA, Christensen H. Is telomere length a biomarker of aging? A review. J Gerontol A Biol Sci Med Sci 2011;66:202-13.
24 Calado RT, Young NS. Telomere diseases. N Engl J Med 2009;361:2353-65.   DOI
25 Bak SH, Kwon SO, Han SS, Kim WJ. Computed tomography-derived area and density of pectoralis muscle associated disease severity and longitudinal changes in chronic obstructive pulmonary disease: a case control study. Respir Res 2019;20:226.   DOI
26 Lynch DA, Austin JH, Hogg JC, Grenier PA, Kauczor HU, Bankier AA, et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology 2015;277:192-205.   DOI
27 Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-8.   DOI
28 Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011;364:897-906.   DOI
29 Babizhayev MA, Yegorov YE. Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large populationbased cohort under the effect of smoking duration. Fundam Clin Pharmacol 2011;25:425-42.   DOI
30 Han Y, Heo Y, Hong Y, Kwon SO, Kim WJ. Correlation between physical activity and lung function in dusty areas: results from the Chronic Obstructive Pulmonary Disease in Dusty Areas (CODA) cohort. Tuberc Respir Dis (Seoul) 2019;82:311-8.   DOI
31 Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.   DOI
32 Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.   DOI
33 Kim V, Davey A, Comellas AP, Han MK, Washko G, Martinez CH, et al. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res 2014;15:52.   DOI
34 O'Callaghan NJ, Fenech M. A quantitative PCR method for measuring absolute telomere length. Biol Proced Online 2011;13:3.   DOI
35 Silverman EK. Exacerbations in chronic obstructive pulmonary disease: do they contribute to disease progression? Proc Am Thorac Soc 2007;4:586-90.   DOI